A Safety Study of ST316 in Participants With Familial Adenomatous Polyposis (FAP).
Clinical trial NCT07729371 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07729371
- Sponsor
- Sapience Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2027-01-04
- Primary completion
- 2028-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.